Struggling With Hair Loss? This First-Ever Prescription Gummy May Help
Best Vitamins for Hair Loss
See at CNET
It's the first prescription hair regrowth gummy to hit the market, and it offers women a more convenient way to stay consistent with treatment, something Hers' chief medical officer and OB-GYN, Dr. Jessica Shepherd, says is often overlooked in traditional regimens.
"The gummy is a once-daily dose that's designed to help women stick to their prescribed hair regimens as deemed clinically necessary by their provider to address their individual needs," she says.
Shepherd told CNET that everything about the product, from the packaging to the vegan formula to the taste (green apple flavor) and texture, was crafted with women's preferences in mind. The goal is a treatment that feels more like a self-care ritual than a chore.
Why a gummy?
Unlike traditional pills or topicals, the Biotin plus Minoxidil Gummy was formulated with adherence in mind. The proprietary compounded formula allows providers to personalize each prescription to individual needs, including adjusting the dosage to minimize side effects or combining multiple ingredients to tackle various concerns simultaneously.
"By leveraging the power of personalization, we're making it possible for women to access treatment designed to address their individual needs for their unique body, lifestyle and goals. This is the benefit of compounding," says Shepherd.
How much does it cost, and where can I get it?
The Biotin plus Minoxidil Gummy is available through Hers after a virtual consultation with one of its licensed providers. Each prescription is customized based on your unique hair loss patterns and goals. Hers strives to offer patients affordable treatments without insurance (no insurance is accepted), and the gummies start at $35 per month.
To learn more or schedule a consultation, visit forhers.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
2 minutes ago
- Fox News
Kansas basketball coach Bill Self hospitalized after encountering 'concerning symptoms' in latest health scare
Bill Self, the longtime head coach of the Kansas men's basketball team, was hospitalized Thursday after he experienced "some concerning symptoms." A university spokesperson confirmed the 62-year-old coach had two stents inserted during a heart procedure. Self remains "in good spirits" and is expected to be discharged from the hospital in the near future. "The procedure went very well, and he is expected to make a full recovery," the school said in a statement. "He is in good spirits and expects to be released from the hospital soon." This isn't the first time Self has been admitted to a hospital after a health scare. In 2023, he missed the Big 12 and NCAA Division I men's basketball tournaments after he experienced chest tightness. Self also contended with balance issues at the time. The two-time national championship-winning coach underwent a heart catheterization and received a pair of stents to treat the blocked arteries. Self has patrolled the Kansas sideline since 2003. In addition to the two national titles, Self coached the Jayhawks to 14 consecutive Big 12 regular-season championships from 2004-2018. In 2017, Self was inducted into the Naismith Memorial Basketball Hall of Fame.
Associated Press
2 minutes ago
- Associated Press
Jaguars DE Josh Hines-Allen says his 7-year-old son Wesley is recovering from leukemia
JACKSONVILLE, Fla. (AP) — Jacksonville Jaguars defensive end Josh Hines-Allen announced Friday that his 7-year-old son, Wesley, is recovering from cancer. Hines-Allen and his wife, Kaitlyn, provided the news in a three-minute video released on social media. They said the diagnosis of acute promyelocytic leukemia came after Wesley spiked a fever and started bleeding from a tooth days before last year's season finale, which Hines-Allen missed for personal reasons. 'It just kind of like hit me, and then nothing else mattered after that,' Hines-Allen said in the video. Wesley underwent chemotherapy for six months. He has a few treatments remaining before he gets to ring the bell next month at Nemours Children's Health in Jacksonville. 'Wesley is doing great,' Kaitlyn said in the video. 'He's swimming every day. He's running around. He's playing sports.' Added Hines-Allen: 'He's got back to being the big brother that he is.' Hines-Allen and his wife also announced Friday that their nonprofit foundation, Four One For All, will launch a season-long campaign called 'Four One For Hope' to give back to four cancer-focused non-profits each month of the NFL regular season. Money raised will go to Nemours Children's Hospital in September, the American Cancer Society in October, the Ronald McDonald House Charities of Jacksonville in October and the National Pediatric Cancer Foundation in December. 'Our goal is to ensure that families going through something similar feel the same level of love and support as we did,' Hines-Allen said in a statement. Hines-Allen is a two-time Pro Bowl pass rusher who has 53 career sacks in six seasons in Jacksonville, two shy of the franchise record held by Tony Brackens. He signed a five-year, $141.25 million contract that included $76.5 million fully guaranteed before the 2024 season. ___ AP NFL:
Yahoo
30 minutes ago
- Yahoo
Centene's Q2 loss: Why health insurers face such big headwinds
Health insurers are navigating rising costs and regulatory challenges, with Centene (CNC) slashing its forecast amid ACA uncertainties. Arthur Wong, S&P Global Ratings healthcare managing director, and Adriel Bettelheim, Axios senior healthcare editor, discuss the impact on the industry and what's ahead. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts here. Managed care company Centene swung to a loss in its most recent quarter, blaming rising Medicare costs and ACA issues during the three-month period. Centene's struggles are part of a broader trend in the health insurance industry. Several insurers this earnings season, including Molina Healthcare and Elevance Health, have called out things like rising costs, regulation, and shifting membership. Here to talk about this backdrop and what it means for the future of the industry are Arthur Wong, S&P Global Ratings Healthcare managing director, and Adriel Bettelheim, senior healthcare editor at Axios. Thank you both for being here. We appreciate it. Happy to be here. Thank you, Julie. So it's interesting in the case of something like a Centene, which slashed its forecast for this year but says it's focused on trying to make its ACA business profitable going ahead into 2026. Adriel, I want to start with you and what we've seen kind of big picture from the health insurance industry, which really seems to be grappling with some of the changes that are happening on the regulatory and reimbursement front. What do you think is or what have you been seeing in your reporting as sort of the biggest challenge there? It's probably the most volatile time for health policy since 2018, and I think some of them in their rate filings, at least, are anticipating both higher costs for care and higher demand. On the policy front, obviously the big beautiful bill Act made the biggest package of changes to Medicaid. And that is going to bring, if estimates hold, about 10 million more uninsured. So there's the prospect of sicker risk pools, more uninsured people showing up in hospital emergency departments. But then also, there's the anticipation that the enhanced Affordable Care Act subsidies, which are due to expire at the end of this year, that the Republicans in Congress won't renew them. So that adds millions more uninsured, not uninsured, but leaving the ACA market. So I think the insurers are all factoring this volatility in, both the higher costs and the changing risk, and it's definitely giving them jitters. And Arthur, how do they possibly navigate in this kind of environment? How do you think they're adapting, and who's sort of doing the best job? Yeah, I mean, it's it's tough to say, in terms of on top of all the legislative changes and the uncertainty being brought about by the BBB Act. I mean, the insurers are already dealing with higher utilization rates for healthcare services, higher costs, and that's coming in from this labor inflation over the last several years. So it's been an issue they've been grappling with since the second half of 2023. So it'll be interesting to see in terms of what they do in terms of cutting costs or trying to lower the utilization. You've seen them trying to increase approval times for procedures. Also, from the service providers' perspective that we cover, we do see them in terms of their collections and in terms of their approvals that those days have stretched out over the past year as well. That's had an impact for the service providers. And Arthur, are there certain insurers that are more and less exposed to certain patient cohorts that will therefore make them sort of more and less vulnerable, or is the industry as a whole affected? I think the whole industry, there are certain providers that are more exposed to the ACA market, the Medicaid market, or the, I mean, Medicare Advantage is also a market that's also been under pressure the last couple of years. So it's it's been a mix, but given how interrelated the whole healthcare system is, it's broadly hit across all of the health insurers. Adriel, I want to ask you as well about UnitedHealth because the company just confirming this week that it was responding to requests from the Justice Department investigators on both the civil and criminal front. There's been some reports about those investigators looking into its Medicare business. And obviously, UnitedHealth has been under a microscope both publicly and regulatorily for a little while now. What have you seen in your reporting in terms of what that means for that company? Yeah, we still don't know a lot of the details of the investigation, but it is, you know, Medicare Advantage insurers are paid more to care for sicker patients. So there is this concern about upcoding, making the patient look sicker and collecting more in payments. And the Trump administration, in general, is looking at overbilling of Medicare by all sorts of providers, making that a priority. So, I think the upcoding, particularly dealing with Optum, the United unit, is definitely a focus. There's also separate antitrust investigations and criminal investigations, which could, you know, relate to a variety of things. So the the admission, bearing out some of the earlier reporting by The Wall Street Journal, I think, puts them under especially close scrutiny. And we'll see if Congress is moved to act. There are some pieces of legislation addressing upcoding in Medicare Advantage that could be part of a deal if they choose to go that far sort of later in the year. Has there been any sort of independent investigation, Adriel, into how prevalent upcoding is and how much, you know, more that insurers are charging as a result of all this? I think there's a general feeling that it's kind of breaks a little bit along partisan lines, but certainly on the Democratic side, there's a feeling that they're overpaid and that there is a certain amount of fraud. And I think the Republicans are kind of, they do love Medicare Advantage historically, and it does now account for more than half of the Medicare enrollees. So there's a reluctance to touch it too much, but I think it is a real concern that there's some more integrity. And that's why some of these proposals are putting it on CMS on the Medicare administrators to do lookbacks and to do a lot more oversight into the billings. Related Videos Open-Source Reigns in US AI Action Plan Charter Communications, Tesla, Volkswagen: Trending Tickers How the Mag 7 Are Driving the Future of AI Capex India's Goyal Sees UK Trade Deal as Win-Win Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
